Notes - Segment Information, Etc.

SAPPORO CLINICAL LABORATORY INC. - Filing #7325055

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
11,058,660,000 JPY
19,556,619,000 JPY
936,757,000 JPY
7,561,201,000 JPY
125,700,000 JPY
19,682,319,000 JPY
10,693,752,000 JPY
1,046,082,000 JPY
8,275,287,000 JPY
20,127,692,000 JPY
20,015,123,000 JPY
112,568,000 JPY
Transactions with other segments
JPY
625,848,000 JPY
625,848,000 JPY
JPY
5,796,000 JPY
631,644,000 JPY
JPY
675,648,000 JPY
JPY
679,062,000 JPY
675,648,000 JPY
3,414,000 JPY
Other items
Depreciation
108,574,000 JPY
400,951,000 JPY
8,291,000 JPY
284,085,000 JPY
2,214,000 JPY
403,165,000 JPY
120,367,000 JPY
7,725,000 JPY
249,577,000 JPY
379,463,000 JPY
377,670,000 JPY
1,792,000 JPY
Increase in property, plant and equipment and intangible assets
193,459,000 JPY
342,408,000 JPY
24,841,000 JPY
124,106,000 JPY
4,035,000 JPY
346,444,000 JPY
139,062,000 JPY
7,462,000 JPY
378,539,000 JPY
525,418,000 JPY
525,064,000 JPY
354,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.